Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.
about
Cloning and characterization of androgen receptor coactivator, ARA55, in human prostateCloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptorGlucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptorInteraction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cellsAndrogen receptor interacts with a novel MYST protein, HBO1LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasionIsolation and characterization of a novel ligand-dependent thyroid hormone receptor-coactivating proteinThe structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactionsEBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistanceComparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinityPromotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cellsThe cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growthMolecular pathology of prostate cancerA network biology approach to prostate cancerPTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycleIdentification of androgen-coregulated protein networks from the microsomes of human prostate cancer cellsAdvances in genetics: widening our understanding of prostate cancerResistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate CancerCurrent opinion on the role of testosterone in the development of prostate cancer: a dynamic modelPrognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysisAbiraterone in the treatment of metastatic castration-resistant prostate cancerRecent progress in pharmaceutical therapies for castration-resistant prostate cancerCrystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosteroneModulation of Androgen Receptor Activation Function 2 by Testosterone and DihydrotestosteroneIdentification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen ReceptorIntegrative clinical genomics of advanced prostate cancer.Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate CancerThe importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistanceTumor susceptibility gene 101 protein represses androgen receptor transactivation and interacts with p300Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6A versatile, bar-coded nuclear marker/reporter for live cell fluorescent and multiplexed high content imagingProstatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epitheliumDifferential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptorRegions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells.Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.Androgen induces a switch from cytoplasmic retention to nuclear import of the androgen receptorAR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progressionSpheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer.
P2860
Q22009024-5D04B1C4-548D-4147-B42F-90EB7048B542Q22009068-0BBF62DA-57A3-41B3-ABA8-39C6C42C45E5Q22254190-CFAB5397-53EA-435E-BE12-336C8B306C21Q22254244-A1E34316-B870-459C-8BE5-F25EC7975929Q22254743-D6A909D9-8A40-4AC5-950E-7940128DCEF3Q24313620-B5D77CFA-966F-4672-84AB-67C5F140F22FQ24336553-974637DE-BB6E-4092-9AFF-9B61A0C92685Q24532004-FE87B4B9-7B33-4576-A8A9-C5A9A63D0EDBQ24646417-B17CC014-6077-4181-B423-DE31CA9B2B3EQ24647922-7A4568C4-5963-4556-A475-459EB30B305BQ24657518-6514C159-8438-4B71-979C-9B0AE99E3C2DQ24658169-DBD27815-BDB7-4C22-A91E-06DC872052FDQ24672410-35873D2D-C39D-4EC4-89C5-F8208A83F2ACQ24678469-74F0DC6A-53B7-4A51-9AF9-FE8D5B6F8053Q24685775-ED1ADF4F-4DE6-4726-9F2F-8DC764445F8FQ24806811-B511427D-8D22-436E-9BBB-510465BC3FBCQ26740628-95441B11-2212-4738-A8F9-00B95F71FF67Q26751237-CB43AC66-7690-44B1-901E-3A98A805D496Q26778886-F3D939CF-AEB3-4F6D-9518-462770CA5150Q26782530-7CFE31C9-9CB6-4788-83E4-C5D7CF44CB92Q26853635-A03DF1F6-A00F-450F-BA41-FF61A32EE953Q27022567-7D1A254F-9085-4044-A320-7480B453253EQ27631345-E954B4FA-8DAC-4E58-BE3E-CA28B2311821Q27646416-67D86A6B-3E80-4BD9-9D76-4BC13C1AB9ADQ27659041-6296E4E3-EDA4-4B54-8280-061218E607BCQ27853170-97E2B6CC-7F94-44DC-A396-BF8ADD398511Q28075965-B173D766-D70D-40D9-8A3C-10E3CC11D384Q28076745-059D571B-4507-4089-A71B-74AE869DCD33Q28141609-5E68BBCE-11B7-4EC6-971E-D68E24A9CDFBQ28208123-614D295E-FA82-41DE-8A49-1E963387DAFCQ28488026-E8F23A59-4C6A-422B-8CD7-0D5E2A85B6AAQ28508802-0CDF9888-648D-4C5F-A7D6-AACA0FE1235DQ28534575-E0CE6A86-3657-41B8-8340-F00545A51C06Q30306146-B7400097-175B-477F-8509-F2F3B4E331B5Q30308047-8EE450AF-ADCE-4A53-A747-BC82EDED1ED3Q30412857-69B639C8-7A2F-40CA-B34B-BAA8CFDEE6C4Q30513836-F43297A5-6384-42BC-B942-4F608FBD90C0Q30585006-0C8E72C7-A6F4-4EBD-B9C9-86AC530A19CBQ30831010-04E77EAA-95ED-46FD-B3FD-474A887A71FBQ31527864-87C941C9-F748-4277-8B5C-F776F2F3B04C
P2860
Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Mutation of the androgen-recep ...... n-independent prostate cancer.
@en
type
label
Mutation of the androgen-recep ...... n-independent prostate cancer.
@en
prefLabel
Mutation of the androgen-recep ...... n-independent prostate cancer.
@en
P2093
P1476
Mutation of the androgen-recep ...... n-independent prostate cancer.
@en
P2093
Shuster TD
Spooner AE
P304
P356
10.1056/NEJM199505253322101
P407
P577
1995-05-01T00:00:00Z